| Martha F Linder, CNM | |
|
143 North Street, Suite #4, D/b/a Auburn Obstetrics & Gynecology, Auburn, NY 13021-1983 | |
| (315) 252-5028 | |
| (315) 252-1587 |
| Full Name | Martha F Linder |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 143 North Street, Suite #4, Auburn, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194034801 | NPI | - | NPPES |
| 03277272 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 001408 (New York) | Primary |
| Entity Name | Upstate Community Medical, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689620163 PECOS PAC ID: 0143238782 Enrollment ID: O20060323000644 |
News Archive
The National Institute on Drug Abuse has agreed to award $2.1 million to Lidong Qin, Ph.D., and Ping Wang, Ph.D., of the Houston Methodist Research Institute to develop a pocket-sized drug test for use in health care settings.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
GCG Marketing today announces its award of Best Corporate Advertisement/Campaign at the 2009 Medical Marketing & Media Awards honoring the agency's development of an awareness campaign for the Children's Neuroblastoma Cancer Foundation.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martha F Linder, CNM 17 Lansing St, Attn: C. Miller, Auburn, NY 13021-1983 Ph: (315) 255-7438 | Martha F Linder, CNM 143 North Street, Suite #4, D/b/a Auburn Obstetrics & Gynecology, Auburn, NY 13021-1983 Ph: (315) 252-5028 |
News Archive
The National Institute on Drug Abuse has agreed to award $2.1 million to Lidong Qin, Ph.D., and Ping Wang, Ph.D., of the Houston Methodist Research Institute to develop a pocket-sized drug test for use in health care settings.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
GCG Marketing today announces its award of Best Corporate Advertisement/Campaign at the 2009 Medical Marketing & Media Awards honoring the agency's development of an awareness campaign for the Children's Neuroblastoma Cancer Foundation.
Pfizer Inc. today announced top-line results from two randomized Phase 3 studies of the irreversible pan-HER kinase inhibitor dacomitinib in patients with advanced non-small cell lung cancer.
› Verified 3 days ago
Marjoria Marie Tracy, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 143 North St, Suite #4, Auburn, NY 13021 Phone: 315-252-5028 Fax: 315-252-5028 | |
Meghan B. Baier, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 143 North St, Suite #4, Auburn, NY 13021 Phone: 315-252-5028 Fax: 315-252-1587 |